Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FWSTU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,552
Award facts
- Contract value 100% obligated
- $23,551.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen auto-injectors with a ceiling value of $23,551.89 under firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. Dupixent (dupilumab) is a biologic immunosuppressant medication used to treat moderate-to-severe atopic dermatitis, moderate-to-severe asthma, and eosinophilic conditions, making this delivery order critical for supporting military and federal healthcare system treatment programs.
This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The SPE2DX vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply an extensive range of pharmaceutical products, specialty medications, vaccines, and medical supplies to military healthcare programs worldwide. AmerisourceBergen's proven track record of competitive pharmaceutical procurement awards and its role as a primary vendor for federal medical supply chains position the company as a critical distributor supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FWSTU?
SPE2DB25FWSTU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FWSTU worth?
The government has obligated $23,552 on SPE2DB25FWSTU.
Is contract SPE2DB25FWSTU an order under another contract?
Yes. SPE2DB25FWSTU is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB25FWSTU competed?
The extent of competition for SPE2DB25FWSTU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award